161 results
Page 2 of 9
6-K
EX-1
opgqyu2v
17 Jul 23
BioLineRx Announces Initiation of Randomized Phase 2 Clinical Trial in First Line Metastatic
7:10am
6-K
EX-99
67i9 zqce
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
jm0fqyc 0wv1
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
p52igsrz
25 Apr 23
Current report (foreign)
7:07am
6-K
EX-99
afu99
17 Apr 23
BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating
11:08am
6-K
EX-99
wnfll4h1z6q ckg
20 Dec 22
BioLineRx Announces Results from Phase 1/2a Study of Investigational
7:08am
6-K
EX-99
203931fyq ftsy9e
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
nns v8ad3nl
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
jvtgk lfsxl
10 Nov 22
Current report (foreign)
7:08am
6-K
EX-99
ta9ukkepsappl97
4 Nov 22
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
4:35pm
6-K
EX-99
ylmxufci
3 Nov 22
BioLineRx Announces Presentations on Cost-Effectiveness of Motixafortide in Multiple Myeloma
9:20am
6-K
EX-99
c26exv2 rywfsh9bz
27 Sep 22
BioLineRx Announces U.S. Commercialization Plan for APHEXDA (Motixafortide) in Stem Cell Mobilization
7:00am
424B5
1rj1r yu5wmd5mwl9x16
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
i22ovh8jn zlk86t
19 Sep 22
BioLineRx Announces $15 Million Registered Direct Offering
8:08am
6-K
EX-99
imp ht42eytzb4n0xrs
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
7mvlik
12 Sep 22
BioLineRx Announces Submission of New Drug Application
8:16am
6-K
EX-99
zpvj ibwn15ux3
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
0yt9jc rh
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
uyc6sq22o
28 Jun 22
BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in
7:14am
6-K
EX-99
6tkvpxefl
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am